+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A Danish population-based cohort study of desmopressin use in adults with nocturia or nocturnal enuresis



A Danish population-based cohort study of desmopressin use in adults with nocturia or nocturnal enuresis



Lower Urinary Tract Symptoms 2018



This study investigated how desmopressin is prescribed to adults in Denmark. All adult users of desmopressin over an 8-year period were identified from the Danish National Prescription Registry. Adult patients with nocturia or nocturnal enuresis (NE) were identified by indication codes for "frequent nocturnal voiding" or "involuntary nocturnal voiding", respectively. Patient demographics, desmopressin formulation and dose, and concomitant medication were investigated. In all, 13 871 adults with nocturia and 2872 adults with chronic (i.e. >10 prescriptions) NE were given 102 547 and 43 712 desmopressin prescriptions, respectively. Across the entire patient cohort, 57% were women and mean patient age was 62 years. Over 40% of prescriptions were to elderly patients (≥65 years), and desmopressin use for adult enuresis increased with age. Orally disintegrating tablets were the most frequently used formulation (57%-65% of prescriptions), and a greater proportion of women than men used low-dose desmopressin (60 μg). Concomitant use of painkillers (opioids: 18%-26.7% of prescriptions; non-steroidal anti-inflammatory drugs: 14.2%-16.4% of prescriptions) and antidepressants (14.4%-18.1% of prescriptions) was common in both conditions, and 5.4%-9.2% of concomitant prescriptions were for overactive bladder medications. This study provides insights into desmopressin use among Danish adults. Nearly half the prescriptions were to patients aged ≥65 years, despite historical manufacturer recommendations that desmopressin be restricted to patients <65 years of age. NE is considered a childhood condition, but desmopressin use for adult NE increased with age. A greater proportion of desmopressin prescriptions to women than men were for the lowest dose, consistent with greater sensitivity to desmopressin in women.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 045012080

Download citation: RISBibTeXText

PMID: 29992760

DOI: 10.1111/luts.12229


Related references

Treatment with desmopressin in nocturia and nocturnal enuresis following traumatic brain injury. Clinical Rehabilitation 10(1): 32-34, 1996

Low-dose oral desmopressin for treatment of nocturia and nocturnal enuresis in patients after radical cystectomy and orthotopic urinary diversion. Bju International 114(5): 727-732, 2015

Similarities and dissimilarities between nocturnal enuresis in childhood and nocturia in adults. Bju International 84 Suppl 1: 9-12, 2000

Comparison of desmopressin, alarm, desmopressin plus alarm, and desmopressin plus anticholinergic agents in the management of paediatric monosymptomatic nocturnal enuresis: a network meta-analysis. Bju International 2018, 2018

Validity and reliability of a questionnaire for evaluating nocturia, nocturnal enuresis and sleep-interruptions in an elderly population. European Urology 49(4): 710-719, 2006

Allergic rhinitis and the associated risk of nocturnal enuresis in children: a population-based cohort study. International Forum of Allergy and Rhinology 8(11): 1260-1266, 2018

Desmopressin for nocturia, incontinence and enuresis. Official Gazette of the United States Patent & Trademark Office Patents 1228(3), Nov 16, 1999

The effect of desmopressin on renal water and solute handling in desmopressin resistant monosymptomatic nocturnal enuresis. Journal of Urology 180(2): 707-13; Discussion 713-4, 2008

Desmopressin Oral Lyophylisate Formulation (Melt): Ameliorating Desmopressin Response In Monosymptomatic Nocturnal Enuresis?. The Journal of Urology 187(4): e240-e241, 2012

Desmopressin alone versus desmopressin and an anticholinergic in the first-line treatment of primary monosymptomatic nocturnal enuresis: a multicenter study. Pediatric Nephrology 29(7): 1195-1200, 2015

Desmopressin is an effective treatment for mixed nocturia with nocturnal polyuria and decreased nocturnal bladder capacity. Journal of Korean Medical Science 25(12): 1792-1797, 2011

Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults. Journal of Clinical Pharmacology 46(10): 1204-1211, 2006

Desmopressin for Nocturia and Enuresis Associated With Multiple Sclerosis. Journal of Urology 162(3): 974-975, 1999

Desmopressin for nocturia and enuresis associated with multiple sclerosis. Annals of PharmacoTherapy 32(1): 114-116, 1998

Randomised placebo-controlled trial of combination treatment of nocturnal enuresis with desmopressin and conditioning alarm in desmopressin non-responders. Pediatric Research 53(4 Part 2): 66A, 2003